Dose adjustment in renal impairment: Response from Martindale: the Complete Drug Reference

BMJ 2005; 331 doi: http://dx.doi.org/10.1136/bmj.331.7511.292-a (Published 28 July 2005)
Cite this as: BMJ 2005;331:292.2

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Sean C Sweetman (sean.sweetman@rpsgb.org), editor
  1. Martindale: the Complete Drug Reference, Royal Pharmaceutical Society of Great Britain, London SE1 7JN

    EDITOR—Vidal et al highlight some of the difficulties that Martindale: the Complete Drug Reference encounters in attempting to evaluate and summarise the published literature, including the licensed prescribing information issued in different countries (p 263).1

    The variation in the details and recommendations is partly explained by the different primary purpose and audience of the publications studied. The British National Formulary (BNF) is probably the busy UK healthcare worker's first port of call and as such reflects current licensed prescribing information and expert opinion in the United Kingdom. I imagine that the same is true for the American Hospital Formulary System Drug Information (AHFS Drug …

    Get access to this article and all of bmj.com for the next 14 days

    Sign up for a 14 day free trial today

    Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL